Advertisement

The TSH levels and risk of hypothyroidism: Results from a population based prospective cohort study in an Iranian adult's population

Published:January 19, 2017DOI:https://doi.org/10.1016/j.ejim.2016.12.019

      Highlights

      • Thyroid autoantibodies and TSH was presented as risk factors for future hypothyroidism.
      • TSH level was a significant predictor for overt hypothyroidism especially in total population and female.
      • A cutoff value of TSH at 2.05 mIU/L was differentiated the overt hypothyroidism patients with from euthyroid.

      Abstract

      Objective

      The aim of current study was to assess the relationship between serum TSH levels and hypothyroidism risk in the euthyroid population.

      Methods

      In a population-based cohort study, a total of 615 individuals with a normal baseline TSH, from of total population (n = 2254) in 2006, were followed up for 6 years. TSH, total T4, thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody (TgAb) were measured. The relative risk (RR) and 95% confidence interval (95%CI) were calculated based on logistic regression. The Receiver Operating Characteristic (ROC) analysis along with area under the curve (AUC) was used to prediction of future hypothyroidism.

      Results

      TSH level in 2006 was a significant predictor for overt hypothyroidism, in the total population (RR = 3.5) and female (RR = 1.37) (all, P value < 0.05). A cutoff value of TSH at 2.05 mIU/L [AUC: (CI95 %), 0.68 (0.44–0.92; P = 0.05)] was obtained for differentiating the patients with overt hypothyroidism from euthyroid. However, this cut off was not observed when we included only negative TPO and TgAbs people in 2006. The RR of hypothyroidism increased gradually when TSH level increased from 2.06–3.6 mIU/L to >3.6 mIU/L in the total population and both sexes. In women, the risk of overt hypothyroidism was significantly higher in subjects with TSH above 3.6 than those subject with THS levels ≤ 2.05 [RR: (CI95 %), 20.57(2.−207.04), P value < 0.05].

      Conclusion

      A cutoff value of TSH at 2.05 mIU/L could predict the development of overt hypothyroidism in future. However, it was not applicable for people with negative TPOAb and negative TgAb.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Canaris G.J.
        • Manowitz N.R.
        • Mayor G.
        • Ridgway E.C.
        The Colorado thyroid disease prevalence study.
        Arch Intern Med. 2000; 160: 526-534
        • Hollowell J.G.
        • Staehling N.W.
        • Flanders W.D.
        • Hannon W.H.
        • Gunter E.W.
        • Spencer C.A.
        • et al.
        Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).
        J Clin Endocrinol Metab. 2002; 87: 489-499
        • Tunbridge W.M.
        • Evered D.C.
        • Hall R.
        • Appleton D.
        • Brewis M.
        • Clark F.
        • et al.
        The spectrum of thyroid disease in a community: the Whickham survey.
        Clin Endocrinol. 1977; 7: 481-493
        • Cappola A.R.
        • Fried L.P.
        • Arnold A.M.
        • Danese M.D.
        • Kuller L.H.
        • Burke G.L.
        • et al.
        Thyroid status, cardiovascular risk, and mortality in older adults.
        JAMA. 2006; 295: 1033-1041
        • Duntas L.H.
        Thyroid disease and lipids.
        Thyroid. 2002; 12: 287-293
        • Bjoro T.
        • Holmen J.
        • Kruger O.
        • Midthjell K.
        • Hunstad K.
        • Schreiner T.
        • et al.
        Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The health study of Nord-Trondelag (HUNT).
        Eur J Endocrinol. 2000; 143: 639-647
        • Jensen E.
        • Petersen P.H.
        • Blaabjerg O.
        • Hansen P.S.
        • Brix T.H.
        • Kyvik K.O.
        • et al.
        Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies.
        Clin Chem Lab Med. 2004; 42: 824-832
        • Kratzsch J.
        • Fiedler G.M.
        • Leichtle A.
        • Brugel M.
        • Buchbinder S.
        • Otto L.
        • et al.
        New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid.
        Clin Chem. 2005; 51: 1480-1486
        • O'Leary P.C.
        • Feddema P.H.
        • Michelangeli V.P.
        • Leedman P.J.
        • Chew G.T.
        • Knuiman M.
        • et al.
        Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study.
        Clin Endocrinol. 2006; 64: 97-104
        • Biondi B.
        • Cooper D.S.
        The clinical significance of subclinical thyroid dysfunction.
        Endocr Rev. 2008; 29: 76-131
        • Baskin H.J.
        • Cobin R.
        • Duick D.
        • Gharib H.
        • Guttler R.
        • Kaplan M.
        • et al.
        American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism.
        Endocr Pract. 2001; 8: 457-469
        • Baloch Z.
        • Carayon P.
        • Conte-Devolx B.
        • Committee G.
        National Academy of Clinical Biochemistry. Laboratory medicine practice guidelines laboratory support for the diagnosis and monitoring of thyroid disease.
        Thyroid. 2003; 13: 3-126
        • Surks M.I.
        • Goswami G.
        • Daniels G.H.
        The thyrotropin reference range should remain unchanged.
        J Clin Endocrinol Metab. 2005; 90: 5489-5496
        • Wartofsky L.
        • Dickey R.A.
        The evidence for a narrower thyrotropin reference range is compelling.
        J Clin Endocrinol Metab. 2005; 90: 5483-5488
        • Brabant G.
        • Beck-Peccoz P.
        • Jarzab B.
        • Laurberg P.
        • Orgiazzi J.
        • Szabolcs I.
        • et al.
        Is there a need to redefine the upper normal limit of TSH?.
        Eur J Endocrinol. 2006; 154: 633-637
        • Vanderpump M.P.
        • Tunbridge W.M.
        • French J.M.
        • Appleton D.
        • Bates D.
        • Clark F.
        • et al.
        The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey.
        Clin Endocrinol. 1995; 43: 55-68
        • Walsh J.P.
        • Bremner A.P.
        • Feddema P.
        • Leedman P.J.
        • Brown S.J.
        • O'Leary P.
        Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques.
        J Clin Endocrinol Metab. 2010 Mar; 95: 1095-1104https://doi.org/10.1210/jc.2009-1977
        • Strieder T.A.
        • Tijssen J.P.
        • Wenzel B.E.
        • Endert E.
        • Wiersinga W.M.
        Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the thyroid events Amsterdam (thea) score.
        Arch Intern Med. 2008; 168: 1657-1663
        • Geul K.
        • Grobbee D.
        • Docter R.
        • Bruyn A.
        • Hooykaas H.
        • Merwe J.
        • et al.
        The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids.
        Clin Endocrinol. 1993; 39: 275-280
        • Teng W.
        • Shan Z.
        • Teng X.
        • Guan H.
        • Li Y.
        • Teng D.
        • et al.
        Effect of iodine intake on thyroid diseases in China.
        N Engl J Med. 2006; 354: 2783-2793
        • Warren R.E.
        • Perros P.
        • Nyirenda M.J.
        • Frier B.M.
        Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screening.
        Thyroid. 2004; 14: 853-857
        • Li Y.
        • Teng D.
        • Shan Z.
        • Teng X.
        • Guan H.
        • Yu X.
        • et al.
        Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes.
        J Clin Endocrinol Metab. 2008; 93: 1751-1757
        • Roos A.
        • Links T.P.
        • de Jong-van den Berg L.T.
        • Gans R.O.
        • Wolffenbuttel B.H.
        • Bakker S.J.
        Thyroid peroxidase antibodies, levels of thyroid stimulating hormone and development of hypothyroidism in euthyroid subjects.
        Eur. J. Intern. Med. 2010; 21: 555-559
        • Aminorroaya A.
        • Janghorbani M.
        • Amini M.
        • Hovsepian S.
        • Tabatabaei A.
        • Fallah Z.
        The prevalence of thyroid dysfunction in an iodine-sufficient area in Iran.
        Arch. Iran. Med. 2009; 12: 262-270
        • Aminorroaya A.
        • Amini M.
        • Rezvanian H.
        • Kachoie A.
        • Sadri G.
        • Mirdamadi M.
        • et al.
        Effects of iodized salt consumption on goiter prevalence in Isfahan: the possible role of goitrogens.
        Endocr Pract. 2001; 7: 95-98
        • Aminorroaya A.
        • Amini M.
        • Hovsepian S.
        Prevalence of hyperthyroidism in Isfahan-Iran, in the year 2006, fifteen years after universal salt iodization: a community based study.
        Acta Endocrinol. 2008; 4: 273-285
        • Spencer C.A.
        • Hollowell J.G.
        • Kazarosyan M.
        • Braverman L.E.
        National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction.
        J Clin Endocrinol Metab. 2007; 92: 4236-4240
        • Effraimidis G.
        • Strieder T.G.
        • Tijssen J.G.
        • Wiersinga W.M.
        Natural history of the transition from euthyroidism to overt autoimmune hypo-or hyperthyroidism: a prospective study.
        Eur J Endocrinol. 2011; 164: 107-113
        • Asvold B.O.
        • Vatten L.J.
        • Midthjell K.
        • Bjoro T.
        Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-year follow-up of the HUNT study in Norway.
        J Clin Endocrinol Metab. 2012 Jan; 97: 93-99https://doi.org/10.1210/jc.2011-1724
        • Mcdermott M.T.
        • Ridgway E.C.
        Subclinical hypothyroidism is mild thyroid failure and should be treated.
        J Clin Endocrinol Metab. 2001; 86: 4585-4590